Psychiatry Research: Neuroimaging
Volume 154, Issue 1 , Pages 69-84 , 15 January 2007

Low-resolution brain electromagnetic tomography (LORETA) identifies brain regions linked to psychometric performance under modafinil in narcolepsy

  • Michael Saletu

      Affiliations

    • Department of Neurology, Medical University of Vienna, Vienna, Austria
    • ,
  • Peter Anderer

      Affiliations

    • Department of Psychiatry, Medical University of Vienna, Vienna, Austria
    • ,
  • Heribert V. Semlitsch

      Affiliations

    • Department of Psychiatry, Medical University of Vienna, Vienna, Austria
    • ,
  • Gerda Maria Saletu-Zyhlarz

      Affiliations

    • Department of Psychiatry, Medical University of Vienna, Vienna, Austria
    • ,
  • Magdalena Mandl

      Affiliations

    • Department of Psychiatry, Medical University of Vienna, Vienna, Austria
    • ,
  • Josef Zeitlhofer

      Affiliations

    • Department of Neurology, Medical University of Vienna, Vienna, Austria
    • ,
  • Bernd Saletu

      Affiliations

    • Department of Psychiatry, Medical University of Vienna, Vienna, Austria
    • Corresponding Author InformationCorresponding author. Section of Sleep Research and Pharmacopsychiatry, Department of Psychiatry, Medical University of Vienna, Währinger Gürtel 18-20, A-1090 Vienna, Austria. Tel.: +43 1 40400 3637/3683; fax: +43 1 4025909.

Received 11 January 2006 ,Revised 15 March 2006 ,Accepted 2 April 2006.

References 

  1. Aguirre M, Broughton R, Stuss D. Does memory impairment exist in narcolepsy-cataplexy?. Journal of Clinical and Experimental Neuropsychology. 1985;7:14–24
  2. American Sleep Disorders Association . The International Classification of Sleep Disorders, Revised Diagnostic and Coding Manual. Rochester; 1997;
  3. Anderer P, Saletu B, Kinsperger K, Semlitsch H. Topographic brain mapping of EEG in neuropsychopharmacology: Part I. Methodological aspects. Methods and Findings in Experimental Clinical Pharmacology. 1987;9:371–384
  4. Anderer P, Semlitsch H, Saletu B, Barbanoj M. Artifact processing in topographic mapping of electroencephalographic activity in neuropsychopharmacology. Psychiatry Research. 1992;45:79–93
  5. Anderer P, Saletu B, Pascual-Marqui RD. Retest reliability of 3D-LORETA estimates of neural generators of classical frequency bands and changes after 5HT1A-agonists (alnespirone and buspirone). Brain topography. Journal of Functional Neurophysiology. 1998;11:72
  6. Anderer P, Saletu B, Semlitsch HV, Pascual-Marqui RD. Perceptual and cognitive event-related potentials in neuropsychopharmacology: methodological aspects and clinical applications (pharmaco-ERP topography and tomography). Methods and Findings in Experimental and Clinical Pharmacology. 2002;24(Suppl C):121–137
  7. Andersson JLR, Onoe H, Hetta J, Lidstrom K, Valind S, Lilja A, et al. Brain networks affected by synchronized sleep visualized by positron emission tomography. Journal of Cerebral Blood Flow and Metabolism. 1998;18:701–715
  8. Arnold W. Der Pauli Test. Anweisung zur sachgemaessen Durchfuehrung, Auswertung und Anwendung des Kraepelinischen Arbeitsversuchs (5, korrigierte Auflage). Berlin: Springer; 1975;
  9. Arruda JE, Walker KA, Weiler MD, Valentino DA. Validation of a right hemisphere vigilance system as measured by principal component and factor analyzed quantitative electroencephalogram. International Journal of Psychophysiology. 1999;32:119–128
  10. Ary JP, Klein SA, Fender DH. Location of sources of evoked scalp potentials: corrections for skull and scalp thickness. IEEE Transactions of Biomedical Engineering. 1981;28:447–452
  11. Baranski JV, Pigeau RA. Self-monitoring cognitive performance during sleep deprivation: effects of modafinil, d-amphetamine and placebo. Journal of Sleep Research. 1997;6:84–91
  12. Baranski J, Cian C, Esquivie D. Modafinil during 64 hr of sleep deprivation: dose-related effects on fatigue, alertness, and cognitive performance. Military Psychology. 1998;10:173–193
  13. Bartenwerfer H. Allgemeine Leistungsdiagnostik. In:  Groffmann KJ,  Michel L editor. Intelligenz-und Leistungsdiagnostik. Bd.. Enzyklopädie der Psychologie. vol. 2:Göttingen: Hogrefe; 1983;
  14. Beck AT, Beamesderfer A. Assessment of depression: the depression inventory. In:  Pichot P editors. Psychological Measurements in Psychopharmacology. Modern Problems in Pharmacopsychiatry. vol. 7:Basel: Karger; 1974;p. 151–169
  15. Becker PM, Schwartz JRL, Feldman N, Hughes RJ. Effect of modafinil on fatigue, mood, and health-related quality of life in patients with narcolepsy. Psychopharmacology. 2004;171:133–139
  16. Billiard M, Besset A, Montplaisir JY, Laffont F, Goldenberg F, Weill JS, et al. Modafinil: a double-blind multicentric study. Sleep. 1994;17:107–112
  17. Brenneis C, Brandauer E, Frauscher B, Schocke M, Trieb T, Poewe W, et al. Voxel-based morphometry in narcolepsy. Sleep Medicine. 2005;6(6):531–536
  18. Broughton R, Ghanem Q, Hishikawa Y, Sugita Y, Nevsimalova S, Roth B. Life effects of narcolepsy in 180 patients from North America, Asia and Europe compared to matched controls. Canadian Journal of Neurological Science. 1981;8:299–304
  19. Broughton R, Low R, Valley V, DaCosta B, Liddiard S. Auditory evoked potentials compared to performance measures and EEG in assessing daytime sleepiness in narcolepsy-cataplexy. Electroencephalography and Clinical Neurophysiology. 1982;54:579–582
  20. Buchsbaum MS, Mendelson WB, Duncan WC, Coppola R, Kelsoe J, Gillin JC. Topographic cortical mapping of EEG sleep stages during daytime naps in normal subjects. Sleep. 1982;5:248–255
  21. Buchsbaum MS, Gillin JC, Wu J, Hazlett E, Sicotte N, Dupont RM, et al. Regional cerebral glucose metabolic rate in human sleep assessed by positron emission tomography. Life Science. 1989;45:1349–1356
  22. Buchsbaum MS, Nuechterlein KH, Haier RJ, Wu J, Sicotte N, Hazlett E, et al. Glucose metabolic rate in normals and schizophrenics during the Continuous Performance Test assessed by positron emission tomography. British Journal of Psychiatry. 1990;156:216–227
  23. Cajochen C, Foy R, Dijk DJ. Frontal predominance of a relative increase in sleep delta and theta EEG activity after sleep loss in humans. Sleep Research Online. 1999;2:65–69
  24. Carskadon MA, Dement WC, Mitler MM, Roth T, Westbrook PR, Keenan S. Guidelines for the multiple sleep latency test (MSLT): a standard measure of sleepiness. Sleep. 1986;9(4):519–524
  25. Chapotot F, Pigeau R, Canini F, Bourdon L, Buguet A. Distinctive effects of modafinil and d-amphetamine on the homeostatic and circadian modulation of the human waking EEG. Psychopharmacology. 2003;166(2):127–138
  26. Chayer, C., Freedman, M., 2001. Frontal lobe function. Current Neurology and Neuroscience Report 1, 547–552.
  27. Cohen RM, Semple WE, Gross M, Holcomb HH, Dowling MS, Nordahl TE. Functional localization of sustained attention: comparison to sensory stimulation in the absence of instruction. Neuropsychiatry, Neuropsychology, and Behavioral Neurology. 1988;1:3–20
  28. Coull JT, Frith CD, Frackowiak RSJ, Grasby PM. A fronto-parietal network for rapid visual information processing: a PET study of sustained attention and working memory. Neuropsychologia. 1996;34:1085–1095
  29. Cross EM, Chaffin WW. Use of the binomial theorem in interpreting results of multiple tests of significance. Educational and Psychological Measurement. 1982;42:25–34
  30. Dahaene S, Tzourio N, Frak V, Raynaud L, Cohen L, Mehler J, et al. Cerebral activations during number multiplication and comparison: a PET study. Neuropsychologia. 1996;34:1097–1106
  31. Dehaene S, Spelke E, Pinel P, Stanescu R, Tsivkin S. Sources of mathematical thinking: behavioral and brain-imaging evidence. Science. 1999;284:970–974
  32. Derogatis LR, Rickels K, Rock A. The SCL-90 and the MMPI: a step in the validation of a new self-report scale. British Journal of Psychiatry. 1976;128:280–289
  33. Deutsch G, Papanicolaou AC, Bourbon WT, Eisenberg HM. Cerebral blood flow evidence of right frontal activation in attention demanding tasks. International Journal of Neuroscience. 1987;36:23–28
  34. Dolan RJ, Paulesu E, Fletcher P. Human memory systems. In:  Frackowiak RSJ,  Friston KJ,  Frith CD,  Dolan RJ,  Mazziotta JC editor. Human Brain Function. San Diego: Academic Press; 1997;p. 367–404
  35. Douglas NJ. The psychosocial aspects of narcolepsy. Neurology. 1998;50:27–30
  36. Drummond SP, Brown GG. The effects of total sleep deprivation on cerebral responses to cognitive performance. Neuropsychopharmacology. 2001;25(5 Suppl):68–73
  37. Findji F, Catani P, Liard C. Topographical distribution of delta rhythms during sleep: evolution with age. Electroencephalograpy and Clinical Neurophysiology. 1981;51:659–665
  38. Finelli LA, Landolt HP, Buck A, Roth C, Berthold T, Borbély AA, et al. Functional neuroanatomy of human sleep states after zolpidem and placebo: a H215O-PET study. Journal of Sleep Research. 2000;9:161–173
  39. Finelli LA, Achermann P, Borbély AA. Individual ‘fingerprints’ in human sleep EEG topography. Neuropsychopharmacology. 2001;25:57–62
  40. Fuster JM. Executive frontal functions. Experimental Brain Research. 2000;133:66–70
  41. Godbout R, Montplaisir J. All day performance variations in normals and narcoleptic subjects. Sleep. 1986;9:200–204
  42. Gasser T, Bacher P, Steinberg H. Test–retest reliability of spectral parameters of the EEG. Electroencephalograpy and Clinical Neurophysiology. 1985;60(4):312–319
  43. Grünberger J, Linzmayer L, Saletu B. Klinische Psychodiagnostik mit Hilfe psychophysiologischer Verfahren [Clinical psychodiagnostics by means of psychophysiological techniques]. Wiener Medizinische Wochenschrift. 1984;134:29–35
  44. Head H. The conception of nervous and mental energy: II. Vigilance: a physiological state of the nervous system. British Journal of Psychology. 1923;14:125–147
  45. Henry GH, Satz P, Heilbronner RL. Evidence of a perceptual-encoding deficit in narcolepsy. Sleep. 1993;16:123–127
  46. Hori T. Spatiotemporal changes of EEG activity during waking–sleeping transition period. International Journal of Neuroscience. 1985;27:101–114
  47. Horrigan JP, Barnhill LJ. Low-dose amphetamine salts and adult attention-deficit/hyperactivity disorder. Journal of Clinical Psychiatry. 2000;61:414–417
  48. Jasinski DR. An evaluation of the abuse potential of modafinil using methylphenidate as a reference. Journal of Psychopharmacology. 2000;14:53–60
  49. Johns MW. A new method for measuring daytime sleepiness: the Epworth Sleepiness Scale. Sleep. 1991;14(6):540–545
  50. Kajimura N, Uchiyama M, Takayama Y, Uchida S, Uema T, Kato M, et al. Activity of midbrain reticular formation and neocortex during the progression of human non-rapid eye movement sleep. Journal of Neuroscience. 1999;19:10065–10073
  51. Krishnan RR, Volow MR, Miller PP, Carwile ST. Narcolepsy: preliminary retrospective study of psychiatric and psychosocial aspects. American Journal of Psychiatry. 1984;141:428–431
  52. Kubicki S, Hermann WM, Fichte K, Freund G. Reflections on the topics: EEG frequency bands and regulation of vigilance. Pharmacopsychiatry. 1978;237–245
  53. Levander S, Sachs C. Vigilance performance and automatic function in narcolepsy: effects of central stimulants. Psychophysiology. 1985;22:24–31
  54. Luo Z, Honda K, Inoué S. Spatio-temporal EEG power spectral patterns during a short daytime nap. Psychiatry and Clinical Neurosciences. 2001;55(3):193–195
  55. Maquet P. Functional neuroimaging of normal human sleep by positron emission tomography. Journal of Sleep Research. 2000;9:207–231
  56. Maquet P, Peters J, Aerts J, Delfiore G, Degueldre C, Luxen A, et al. Functional neuroanatomy of human rapid-eye-movement sleep and dreaming. Nature. 1996;383:163–166
  57. Mitler MM, Guajavarty KS, Sampsom MG, Browman . Multiple daytime nap approaches to evaluating the sleep patient. Sleep. 1982;5:119–127
  58. Mitler MM, Harsh J, Hirshkowitz M, Guilleminault C. Long-term efficacy and safety of modafinil (PROVIGIL®) for the treatment of excessive daytime sleepiness associated with narcolepsy. Sleep Medicine. 2000;1:231–243
  59. Mosko S, Zetin M, Glen S, Garber D, DeAntonio M, Sassin J, et al. Self-reported depressive symptomatology, mood ratings, and treatment outcome in sleep disorders patients. Journal of Clinical Psychology. 1989;45:51–60
  60. Naumann A, Daum I. Narcolepsy: pathophysiology and neuropsychological changes. Behavioral Neurology. 2003;14(3–4):89–98
  61. Ollo C, Squires N, Pass H, Walsleben J, Baker T, Gujavarty K. Electrophysiological and neuropsychological assessment of cognitive function in narcolepsy. Sleep Research. 1987;16:402
  62. Overeem S, Mignot E, van Dijk JG, Lammers GJ. Narcolepsy: clinical features, new pathophysiologic insights, and future perspectives. Journal of Clinical Neurophysiology. 2001;18:78–105
  63. Palfai T, Jankiewicz H. Amphetamine and cocaine. In:  Ring DM editors. Drugs and Human Behavior.. Dubuque: Brown; 1991;p. 281–309
  64. Pardo JV, Fox PT, Raichle ME. Localization of a human system for sustained attention by positron emission tomography. Nature. 1991;349:61–64
  65. Pascual-Marqui RD, Michel CM, Lehmann D. Low resolution electromagnetic tomography: a new method for localizing electrical activity in the brain. International Journal of Psychophysiology. 1994;18:49–65
  66. Pascual-Marqui RD, Lehmann D, Koenig T, Kochi K, Merlo MC, Hell D, et al. Low resolution brain electromagnetic tomography (LORETA) functional imaging in acute, neuroleptic-naive, first-episode, productive schizophrenia. Psychiatry Research: Neuroimaging. 1999;90:169–179
  67. Pauli R, Arnold W. The Pauli-Test, Its Correct Execution and Evaluation in BK. Oxford, England: J.A. Barth; 1953;76 pp.
  68. Pigeau R, Naitoh P, Buguet A, McCann C, Baranski J, Taylor M, et al. Modafinil, d-amphetamine and placebo during 64 hours of sustained mental work: effects on mood, fatigue, cognitive performance and body temperature. Journal of Sleep Research. 1995;4:212–228
  69. Pollack CP, Wagner DR, Moline ML, Monk TH. Cognitive and motor performance of narcoleptic and normal subjects living in temporal isolation. Sleep. 1992;15:202–211
  70. Portas CM, Rees G, Howseman AM, Josephs O, Turner R, Frith CD. A specific role for the thalamus in mediating the interaction of attention and arousal in humans. Journal of Neuroscience. 1998;18:8979–8989
  71. Posner MI, Petersen SE. The attention system of the human brain. Annual Review of Neuroscience. 1990;13:25–42
  72. Rezai K, Andreasen NC, Alliger R, Cohen G, Swayze V, O'Leary DS. The neuropsychology of the prefrontal cortex. Archives of Neurology. 1993;50:636–642
  73. Rogers AE, Rosenberg RS. Tests of memory in narcoleptics. Sleep. 1990;13(1):42–52
  74. Roland PE, Friberg L. Localization of cortical areas activated by thinking. Journal of Neurophysiology. 1985;53:1219–1243
  75. Roy A. Psychiatric aspects of narcolepsy. British Journal of Psychiatry. 1976;128:562–565
  76. Saletu B, Grünberger J, Linzmayer L, Stöhr H. Pharmaco-EEG, psychometric and plasma level studies with two novel alpha-adrenergic stimulants CRL 40476 and 40028 (Adrafinil) in elderlies. New Trends in Experimental and Clinical Psychiatry. 1986;5–31
  77. Saletu B, Saletu M, Grünberger J, Frey R, Anderer P, Mader R. Treatment of the alcoholic organic brain syndrome: double-blind, placebo-controlled clinical, psychometric and electroencephalographic mapping studies with modafinil. Neuropsychobiology. 1993;27:26–39
  78. Saletu B, Anderer P, Saletu-Zyhlarz GM, Pascual-Marqui RD. EEG topography and tomography in diagnosis and treatment of mental disorders: evidence for a key-lock principle. Methods and Findings in Experimental and Clinical Pharmacology. 2002;24(Suppl D):97–106
  79. Saletu M, Anderer P, Saletu-Zyhlarz GM, Mandl M, Arnold O, Zeitlhofer J, et al. EEG-tomographic studies with LORETA on vigilance differences between narcolepsy patients and controls and subsequent double-blind, placebo-controlled studies with modafinil. Journal of Neurology. 2004;251:1354–1363
  80. Saletu M, Anderer P, Saletu-Zyhlarz GM, Mandl M, Arnold O, Nosiska D, et al. EEG-mapping differences between narcolepsy patients and controls and subsequent double-blind, placebo-controlled studies with modafinil. European Archives of Psychiatry and Clinical Neuroscience. 2005;255:20–32
  81. Schuhfried G. Wiener Reaktionstest. Version 3.00. Mödling; 1997;
  82. Smith KM, Merritt SL, Cohen FL. Can we predict cognitive impairments in persons with narcolepsy?. Loss, Grief and Care. 1992;5(3/4):103–113
  83. Smulders FTY, Kenemans JL, Jonkman LM, Kok A. The effects of sleep loss on task performance and the electroencephalogram in young and elderly subjects. Biological Psychology. 1997;45:217–239
  84. Spielberger CD, Gorsuch RL, Lushene RE. STAI, Manual for the State-Trait-Anxiety-Inventory. Palo Alto: Consulting Psychologists Press; 1970;
  85. Talairach J, Tournoux P. Co-Planar Stereotaxic Atlas of the Human Brain. Stuttgart: Thieme; 1988;
  86. Thomas M, Sing H, Belenky G, Holcomb H, Mayberg H, Dannals R, et al. Neural basis of alertness and cognitive performance impairments during sleepiness: I. Effects of 24 hours of sleep deprivation on waking human regional brain activity. Journal of Sleep Research. 2000;9:335–352
  87. Towle VL, Bolanos J, Suarez D, Tan K, Grzeszczuk R, Levin DN, et al. The spatial location of EEG electrodes: locating the best-fitting sphere relative to cortical anatomy. Electroencephalography and Clinical Neurophysiology. 1993;86:1–6
  88. Turner DC, Robbins TW, Clark L, Aron AR, Dowson J, Sahakian BJ. Cognitive enhancing effects of modafinil in healthy volunteers. Psychopharmacology. 2003;165:260–269
  89. US Modafinil in Narcolepsy Multicenter Study Group . Randomized trial of modafinil for the treatment of pathological somnolence in narcolepsy. Annals of Neurology. 1998;43:88–97
  90. US Modafinil in Narcolepsy Multicenter Study Group . Randomized trial of modafinil as a treatment for the excessive daytime somnolence of narcolepsy. Neurology. 2000;54:1166–1175
  91. Valley V, Broughton R. Daytime performance deficits and physiological vigilance in untreated patients with narcolepsy-cataplexy compared to controls. Revue d'Electroencéphalographie et de Neurophysiologie Clinique. 1981;55:243–251
  92. Valley V, Broughton R. The physiological (EEG) nature of drowsiness and its relation to performance deficits in narcoleptics. Electroencephalography and Clinical Neurophysiology. 1983;55:243–251
  93. Von Zerssen D, Koeller DM, Rey ER. Die Befindlichkeitsskala (B-S): Ein einfaches Instrument zur Objektivierung von Befindlichkeitsstörungen, insbesondere im Rahmen von Längsschnittuntersuchungen. Arzneimittelforschung [Drug Research]. 1970;20:915–918
  94. Weber DL, Clark CR, McFarlane AC, Moores KA, Morris P, Egan GF. Abnormal frontal and parietal activity during working memory updating in post-traumatic stress disorder. Psychiatry Research: Neuroimaging. 2005;140:27–44
  95. Werth E, Achermann P, Borbély AA. Brain topography of the human sleep EEG: antero-posterior shifts of spectral power. NeuroReport. 1996;8:123–127
  96. Werth E, Achermann P, Borbély AA. Fronto-occipital EEG power gradients in human sleep. Journal of Sleep Research. 1997;6:102–112
  97. Wisor JP, Nishino S, Sora I, Uhl GH, Mignot E, Edgar DM. Dopaminergic role in stimulant-induced wakefulness. Journal of Neuroscience. 2001;21(5):1787–1794
  98. Wu JC, Gillin JC, Buchsbaum MS, Hershey T, Hazlett E, Sicotte N, et al. The effect of sleep deprivation on cerebral glucose metabolic rate in normal humans assessed with positron emission tomography. Sleep. 1991;14:155–162

PII: S0925-4927(06)00067-9

doi: 10.1016/j.pscychresns.2006.04.005

Psychiatry Research: Neuroimaging
Volume 154, Issue 1 , Pages 69-84 , 15 January 2007

Article Tools

* Image Usage & Resolution